← Back to Clinical Trials
Recruiting NCT07762664

NCT07762664 Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patients With Carotid Artery Stenosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07762664
Status Recruiting
Phase
Sponsor Chinese PLA General Hospital
Condition Carotid Artery Stenosis
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2026-01-07
Primary Completion 2029-01-07

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 90 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2026-01-07 with a primary completion date of 2029-01-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective observational study aims to compare photon-counting detector computed tomography angiography (PCD-CTA) with conventional energy-integrating detector computed tomography angiography (EID-CTA) for the assessment of carotid atherosclerotic plaques in patients with carotid artery stenosis.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older. * Patients with carotid atherosclerotic plaque or carotid artery stenosis. * Patients scheduled to undergo carotid artery stenting. * Patients undergoing preprocedural carotid CTA examination. * Ability to provide written informed consent. Exclusion Criteria: * Known allergy to iodinated contrast material. * Severe renal insufficiency or other contraindications to contrast-enhanced CT. * Pregnancy or suspected pregnancy. * Severe motion or other artifacts resulting in nondiagnostic image quality. * Incomplete clinical or imaging data.

Contact & Investigator

Central Contact

Jinhao Lyu, MD

✉ 330322990@qq.com

📞 +8615903562929

Principal Investigator

Xin Lou

STUDY CHAIR

Chinese PLA General Hospital

Frequently Asked Questions

Who can join the NCT07762664 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 90 Years, studying Carotid Artery Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07762664 currently recruiting?

Yes, NCT07762664 is actively recruiting participants. Contact the research team at 330322990@qq.com for enrollment information.

Where is the NCT07762664 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT07762664 clinical trial?

NCT07762664 is sponsored by Chinese PLA General Hospital. The principal investigator is Xin Lou at Chinese PLA General Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology